Bos, V., Crouwel, F., Waaijenberg, P., Bouma, G., Duijvestein, M., Buiter, H., Brand, H., Hamer, H. and de Boer, N. 2022. Salivary Calprotectin Is not a Useful Biomarker to Monitor Disease Activity in Patients with Inflammatory Bowel Disease. Journal of Gastrointestinal and Liver Diseases. 31, 3 (Sep. 2022), 283-289. DOI:https://doi.org/10.15403/jgld-4215.